Table 4.

Prevalence of combined immunotypes defined by ER, CK14, and CK5/6 and adjusted ORs

ERCK14CK5/6BRCA1 (%)Control (%)Adj OR (95% CI)
Pos9.667.21
NegNegNeg20.924.04.15 (1.76-9.82)
NegNegPos13.42.426.9 (7.18-101.1)
NegPosNeg12.44.814.01 (3.41-57.5)
NegPosPos43.81.6147.9 (35.2-621.3)
  • Abbreviations: CK, cytokeratin; adj OR, adjusted OR; Neg, negative; Pos, positive.